Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Novel therapies for children with severe asthma
Top Ten Searches
hla beta 2 probiotics hypo allergenic scid urticaria aeroallergens asthma angioedema hivYour Article Summary
The Impact of Pneumococcal Conjugate Vaccine on Rates of Myringotomy With Ventilation Tube Insertion in Australia
The Pediatric Infectious Disease Journal, 06/26/09
Jardine A et al. - Although ecologic data such as this have limitations, the significant differential effects observed by time period and age group are suggestive of a vaccine effect of similar magnitude to that documented by postmarketing surveillance in the United States. The rapid uptake of 7vPCV in Australia, including catch up to 2 years of age, is an important difference to the United States and it is possible that an even greater effect would have been observed with a booster dose in the second year of life. Longer term data will be needed to fully assess the role of a booster dose.
Related Articles
Construct validity of a simulator for myringotomy with ventilation tube insertion
Otolaryngology Head and Neck Surgery, 10/27/09
Relevance Score: 85%
The Effect of Topical Combined Ciprofloxacin 0.3% and Dexamethasone 0.1% on Children with Otitis Media with Effusion(OME) Undergoing Myringotomy
Middle East Journal of Family Medicine, 10/21/09
Relevance Score: 85%
Acupuncture management of pain and emergence agitation in children after bilateral myringotomy and tympanostomy tube insertion
Paediatric Anaesthesia, 10/08/09
Relevance Score: 80%
Today in Vaccine/Immunotherapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Efficacy and Safety of Pentavalent Human-Bovine Reassortant Rotavirus Vaccine When Administered With Greater Than 10 Weeks Between Doses
The Pediatric Infectious Disease Journal, 12/17/09
A virosomal formulated Her-2/neu multi-peptide vaccine induces Her-2/neu-specific immune responses in patients with metastatic breast cancer: a phase I study
Breast Cancer Research and Treatment, 12/17/09
Trial of 2009 Influenza A (H1N1) Monovalent MF59-Adjuvanted Vaccine
New England Journal of Medicine, 12/16/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


